MarketsandMarkets

qPCR and dPCR Virtual Conference [ Time Zone - Central European Time]

15th April 2021

12+

Speakers

100+

Attendees

Advancing qPCR and dPCR technological developments and its applications in oncology and infectious disease diagnostics

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

MarketsandMarkets are proud to host its inaugural “qPCR and dPCR Virtual Conference” which will be held on 15th - 16th April 2021. The conference will focus on the latest developments in digital and real time PCR and also, its application in cancer diagnosis and infectious disease diagnostics.

WHAT TO EXPECT

  • New developments in qPCR and dPCR
  • Introduction, Benefits, Future Development of dPCR and qPCR
  • Applications of qPCR and dPCR in cancer diagnosis and infectious diseases diagnostics
  • Data Analysis and Standardization
  • Latest technologies used in qPCR and dPCR and how it helps in clinical diagnostics
     

From Universities and Pharma/Therapeutic Companies

Professors, Lecturers, Scientists, Researchers, Lab Heads, Managers, Directors working in-

  • qPCR
  • Digital PCR
  • NGS
  • Assay Development
  • Infectious Diseases
  • Microbiology
  • Oncology
  • Bioinformatics
  • Data Analysis
  • Genomics
  • Single Cell Analysis

 

CONFERENCE AGENDA

Online Registrations

13:30 - 13:50

Welcome note from MarketsandMarkets

13:50 - 13:55

Opening Remarks from the Chairman

David Zarling

David Zarling, CEO, Colby Pharmaceuticals, USA

13:55 - 14:00

NEW DEVELOPMENTS IN QPCR AND DPCR

Keynote Presentation: The naica® system, a flexible digital PCR solution for assay development: application to wastewater-based epidemiology of Covid-19

14:00 - 14:30

Customized approach for sample management & product development

Preeti Panda

Preeti Panda, Head Business Development, INVITEK Molecular, Germany

14:30 - 15:00

PCR|ONE: 15 minute Point of Care PCR for screening and for syndromic testing

Piotr Garstecki

Piotr Garstecki, Co-Founder, Scope Fluidics, Poland

15:00 - 15:30

APPLICATIONS OF QPCR AND DPCR IN CANCER DIAGNOSIS AND INFECTIOUS DISEASES DIAGNOSTICS

Applications of qPCR and dPCR in cancer and infectious diseases diagnostics

15:30 - 16:00

One-to-One Networking Break on Event Portal

16:00 - 16:00

SPEAKERS

David Zarling

David Zarling

CEO, Colby Pharmaceuticals, USA

Valerie Taly

Valerie Taly

Research Director, CNRS, INSERM, France

Andreas Weinhaeusel

Andreas Weinhaeusel

Thematic Coordinator, Molecular Diagnostics, AIT Austrian Institute of Technology, Austria

Wim Trypsteen

Wim Trypsteen

Faculty of Medicine and Health Sciences, Ghent University, Europe

Michael Powell

Michael Powell

Chief Scientific Officer, DiaCarta, USA

Preeti Panda

Preeti Panda

Head Business Development, INVITEK Molecular, Germany

Piotr Garstecki

Piotr Garstecki

Co-Founder, Scope Fluidics, Poland

Tim Julian

Tim Julian

Eawag, Switzerland, Group Leader in the Department of Environmental Microbiology

Allison Mallory

Allison Mallory

Director of Molecular Biology R&D, Stilla Technologies, France

SPONSORS

PARTNERS